Originally posted by aslyfox from what I have read, certain proposals are at different stages. that is not what I am saying
If they follow the necessary safety protocols, which takes time that is one thing
if they are rushing the job in order to produce a miracle on an artificial deadline and it turns out they screwed up
that is a horse of a different color
supposedly, the " oxford " is on the old track but advanced and might, might be available sometime next year
as far as what is covered by the act, I haven't researched that.
all I can say is that one of the announced goals of one major political party is to give manufacturers immunity from liability for producing a new vaccine for this virus
I wonder why if it is already covered ?
I don't know, as my expectation is that this vaccine will likely be recommended for children, at least eventually.
The issue to me with speeding the process mainly has to do with the fear that the government will back the wrong vaccine. Not all vaccines are created equal. Zostavax was the only shingles vaccine for a long time, but now there is a better one, Shingrix. When you choose a vaccine to back, early in the process, you may back one that isn't as effective as other vaccines in development or, of course one that has more side effects.
Obviously, if the government backs a vaccine and tells a company to go forward with development, there will still be testing done on it. If it turned out to have some really bad side effect, say, Guillain-Barre, then they would have wasted that money and time and would have to choose a different vaccine. But there is a distinct possibility that they choose a vaccine that is adequate, has minimal side effects and they can then vaccinate the public by the beginning of next year.
Basically, they are trying to shave 5 or 6 months off of the development process.